News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Federica Pecci: Factors linked to prolonged disease control after stopping ICIs for irAEs in advanced NSCLC
Federica Pecci/X
Apr 26, 2025, 16:35

Federica Pecci: Factors linked to prolonged disease control after stopping ICIs for irAEs in advanced NSCLC

Federica Pecci, Research Fellow at Dana-Farber Cancer Institute, shared a post on X about a paper she co-authored with colleagues published in Clinical Cancer Research,:

“Just published in Clinical Cancer Research, our work studying factors associated with prolonged disease control and survival after discontinuation of immune checkpoint inhibitors for irAEs in patients with advanced NSCLC.”

“Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non–Small Cell Lung Cancer”

Authors: Federica Pecci, Rohit Thummalapalli, Stephanie Alden, Biagio Ricciuti, Joao Alessi, Mizuki Nishino, Bruce Johnson, Matthew Hellmann, Adam Schoenfeld, Mark Awad et al.

Federica Pecci: Factors linked to prolonged disease control after stopping ICIs for irAEs in advanced NSCLC

More posts featuring Federica Pecci.

Adam Schoenfeld Biagio Ricciuti Bruce Johnson cancer Clinical Cancer Research Federica Pecci João Alessi Mark Awad Matthew Hellmann Mizuki Nishino non small cell lung cancer NSCLC OncoDaily Oncology Rohit Thummalapalli Stephanie Alden
Special Coverage
Science
Apr 26, 2025, 16:35
Federica Pecci: Factors linked to prolonged disease control after stopping ICIs for irAEs in advanced NSCLC
Blog
Apr 26, 2025, 16:27
Patricia Spears will chair the AACR 25 Patient Advocate Poster Symposium - AACR
Blog
Apr 26, 2025, 16:17
Margaret Foti: We are making final preparations for the AACR 25 Opening Ceremony and Opening Plenary
Science
Apr 26, 2025, 16:07
Anup Trikannad shares findings on IVIG prophylaxis benefits in BCMA-directed bispecific therapy for MM
Blog
Apr 26, 2025, 15:56
Allison Rosen joins AACR Scientists–Survivor program as mentor
Career
Apr 26, 2025, 15:39
Fadlo Khuri: Greatly honored to have been elected to the American Academy of Arts and Sciences
Blog
Apr 26, 2025, 15:35
Elizabeth McKenna highlights Eli Van Allen's review on artificial intelligence in oncology
Insight
Apr 26, 2025, 15:08
Patrick Hwu: Can low-dose gut irradiation enhance the effectiveness of PD-L1 blockade in metastatic cancer?
Blog
Apr 26, 2025, 15:06
Touching on 2nd opinions, scanxiety, communication styles and cultural sensitivity - Lung Cancer Europe
Blog
Apr 26, 2025, 14:51
Yüksel Ürün: Expanding horizons in MIBC treatment
Science
Apr 26, 2025, 14:34
Talha Badar: Venetoclax plus 3+7 for newly diagnosed acute myeloid leukemia
Blog
Apr 26, 2025, 14:16
POEM 2025 Scientific Meeting: Key Sessions, Workshops, and Why You Should Attend